- Home
- FULC vs CTO Comparison
FULC vs CTO Comparison
Compare FULC & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FULC | CTO |
|---|---|---|
| Founded | 2015 | 1902 |
| Country | United States | United States |
| Employees | N/A | 42 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 718.4M | 643.7M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | FULC | CTO |
|---|---|---|
| Price | $7.93 | $19.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | $16.38 | ★ $21.50 |
| AVG Volume (30 Days) | ★ 1.0M | 256.1K |
| Earning Date | 05-19-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.69% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.63 |
| Revenue Next Year | N/A | $2.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.32 | $15.07 |
| 52 Week High | $15.74 | $20.25 |
Technical Indicators
Market Signals| Indicator | FULC | CTO |
|---|---|---|
| Relative Strength Index (RSI) | 34.80 | 60.19 |
| Support Level | $6.33 | $17.29 |
| Resistance Level | $8.50 | $20.25 |
| Average True Range (ATR) | 0.80 | 0.42 |
| MACD | -0.17 | -0.01 |
| Stochastic Oscillator | 9.31 | 50.37 |
Price Performance
Historical ComparisonAbout FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a real estate investment trust company, that owns income properties in diversified markets in the United States. The company operates in four primary business segments: Income properties, management services, commercial loans and investments, and real estate operations. It derives maximum revenue from Income Properties.